查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1488255

动态血压监测设备市场 - 按设备类型（产品 [数位、无液、水银]、配件）、操作（自动、半自动、手动）、配置（便携式、桌上型、落地式、壁挂式） - 全球预测，2024 年- 2032

Ambulatory Blood Pressure Monitoring Devices Market - By Device Type (Products [Digital, Aneroid, Mercury], Accessories), Operation (Automatic, Semi-automatic, Manual), Configuration (Portable, Desk Mounted, Floor, Wall) - Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在全球高血压和相关心血管疾病盛行率不断上升的推动下，动态血压监测设备市场规模预计在 2024 年至 2032 年间将以 8.5% 的复合年增长率成长。据世界卫生组织称，全世界三分之一的成年人患有高血压。动态血压监测 (ABPM) 装置可在 24 小时内连续、非侵入性地监测血压，为医疗保健专业人员提供有关患者血压波动的宝贵见解。对预防性医疗保健和早期疾病检测的日益重视也推动了产品的采用。

动态血压监测设备的技术不断进步，为开发具有更高准确性和舒适度的紧凑型穿戴式装置铺平了道路。医疗保健支出的增加，加上政府和医疗保健组织促进远距患者监护设备使用的措施将决定市场的成长。

动态血压监测设备产业根据设备类型、操作、配置和地区进行分类。

在预测期内，配件设备类型细分市场的市场规模将产生可观的收入，复合年增长率为 8.2%。越来越多地采用动态血压监测设备来长期监测高血压，因此需要相容的配件来确保准确可靠的测量。袖带、转接器和软体解决方案等配件也有助于增强功能和产品可用性，从而推动产品需求。

手动操作领域的动态血压监测设备市场预计2024 年至2032 年间复合年增长率为7.9%。专业人员的青睐。手动血压监测仪也比自动血压监测仪更具成本效益，使其可供更广泛的医疗机构和患者使用，特别是在资源有限的环境中。

由于高血压和心血管疾病盛行率不断上升，亚太地区动态血压监测设备市场预计在 202-2032 年期间复合年增长率为 9.4%。快速的技术进步，例如紧凑且用户友好的 ABPM 设备的开发，鼓励了医疗保健专业人员和患者的采用。医疗保健支出的增加、人们对定期血压监测重要性的认识不断提高以及政府为促进预防性医疗保健措施而采取的有利倡议也将刺激该区域市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 高血压和心血管疾病盛行率增加
      • 越来越重视预防保健
      • 技术进步
    • 产业陷阱与挑战
      • 血压监测设备成本高昂
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 2023 年定价分析
  • 波特的分析
  • PESTEL分析
  • 报销场景
  • 未来市场趋势
  • 缺口分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按设备类型，2018 年 - 2032 年

  • 主要趋势
  • 产品
    • 数位血压监测仪
      • 上臂监视器
      • 腕式监视器
      • 手指监视器
    • 无液体血压监测仪
    • Mercury 血压监测仪
  • 配件

第 6 章：市场估计与预测：按营运划分，2018 年 - 2032 年

  • 主要趋势
  • 自动的
  • 半自动
  • 手动的

第 7 章：市场估计与预测：按配置，2018 - 2032 年

  • 主要趋势
  • 便携的
  • 桌面安装式
  • 落地式
  • 壁挂式

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • A&D Company, Limited
  • American Diagnostic Corporation
  • Beurer GmbH
  • Contec
  • Dr. Morepen
  • ForaCare, Inc.
  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • iHealth Labs Inc
  • Koninklijke Philips N.V.
  • Microlife Corporation
  • OMRON Corporation
  • Rossmax International Ltd.
简介目录
Product Code: 8573

Ambulatory blood pressure monitoring devices market size is anticipated to grow at 8.5% CAGR between 2024 and 2032, driven by the rising prevalence of hypertension and related cardiovascular diseases worldwide. As per who, hypertension affects 1 in 3 adults worldwide. Ambulatory blood pressure monitoring (ABPM) devices offer continuous and non-invasive monitoring of blood pressure over a 24-hour period for providing healthcare professionals with valuable insights into patient blood pressure fluctuations. The growing emphasis on preventive healthcare and early disease detection is also driving the product adoption.

Growing technological advancements in ambulatory blood pressure monitoring devices have made way for the development of compact and wearable devices with enhanced accuracy and comfort. Rising healthcare expenditure, coupled with initiatives by governments and healthcare organizations to promote the use of remote patient monitoring devices will define the market growth.

The ambulatory blood pressure monitoring devices industry is classified based on device type, operation, configuration, and region.

The market size from the accessories device type segment will generate notable revenue at 8.2% CAGR during the forecast period. The increasing adoption of ambulatory blood pressure monitoring devices for long-term monitoring of hypertension is necessitating the need for compatible accessories to ensure accurate and reliable measurements. Accessories, such as cuffs, adapters, and software solutions also help in enhancing the functionality and product usability, thereby driving the product demand.

Ambulatory blood pressure monitoring devices market from the manual operation segment is anticipated to witness 7.9% CAGR between 2024 and 2032. Despite the emergence of automated monitoring devices, manual ambulatory blood pressure monitors continue to be preferred by healthcare professionals for their accuracy and reliability in measuring BP. Manual BP monitors are also more cost-effective than automated alternatives, making them accessible to a wider range of healthcare facilities and patients, especially in resource-constrained settings.

Asia Pacific ambulatory blood pressure monitoring devices market is projected to exhibit 9.4% CAGR during 202-2032, attributed to the rising prevalence of hypertension and cardiovascular diseases. Rapid technological advancements, such as the development of compact and user-friendly ABPM devices, have encouraged their adoption among both healthcare professionals and patients. The increasing healthcare expenditure, growing awareness about the importance of regular blood pressure monitoring, and favorable government initiatives for promoting preventive healthcare measures will also stimulate the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of hypertension and cardiovascular diseases
      • 3.2.1.2 Growing focus on preventive healthcare
      • 3.2.1.3 Technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with blood pressure monitoring devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Pricing analysis, 2023
  • 3.7 Porter's analysis
    • 3.7.1 Supplier power
    • 3.7.2 Buyer power
    • 3.7.3 Threat of new entrants
    • 3.7.4 Threat of substitutes
    • 3.7.5 Industry rivalry
  • 3.8 PESTEL analysis
  • 3.9 Reimbursement scenario
  • 3.10 Future market trends
  • 3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Products
    • 5.2.1 Digital BP monitors
      • 5.2.1.1 Upper arm monitors
      • 5.2.1.2 Wrist monitors
      • 5.2.1.3 Finger monitors
    • 5.2.2 Aneroid BP monitors
    • 5.2.3 Mercury BP monitors
  • 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Operation, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Automatic
  • 6.3 Semi-automatic
  • 6.4 Manual

Chapter 7 Market Estimates and Forecast, By Configuration, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Portable
  • 7.3 Desk mounted
  • 7.4 Floor standing
  • 7.5 Wall mounted

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 A&D Company, Limited
  • 9.2 American Diagnostic Corporation
  • 9.3 Beurer GmbH
  • 9.4 Contec
  • 9.5 Dr. Morepen
  • 9.6 ForaCare, Inc.
  • 9.7 GE HealthCare Technologies Inc.
  • 9.8 Hill-Rom Holdings, Inc.
  • 9.9 iHealth Labs Inc
  • 9.10 Koninklijke Philips N.V.
  • 9.11 Microlife Corporation
  • 9.12 OMRON Corporation
  • 9.13 Rossmax International Ltd.